Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06780241 · ClinicalTrials.gov registry record
Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease
A clinical trial of Aortic Stenosis and Mitral Regurgitation, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06780241 is a study of Aortic Stenosis and Mitral Regurgitation that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 200 participants, below the 1,355-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06780241, a study of Aortic Stenosis and Mitral Regurgitation, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This project aims to validate sex-specific biologic signatures associated with aortic valve disease developed in a large multicenter CMR registry, using unsupervised phenomapping. The aim to use standard and advanced CMR techniques (MRF, DTI, chemical exchange transfer, and radiomics analysis) is to determine advanced CMR predictors of reverse remodeling following aortic valve surgery and develop sex-specific thresholds for risk. Infrastructure developed by this study will enable development of an innovative, scalable, sex-specific precision medicine cardiovascular imaging pipeline to determine overall risk and treatment response.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST CMR
- OTHER Quality of Life Questionnaire
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-12-10 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06780241
The ClinicalTrials.gov registry entry for NCT06780241 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,355-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (85% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Aortic Stenosis appearing as the primary indexed condition, and to 2 interventions - of which CMR is the first listed.
NCT06780241 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06780241 about?
NCT06780241 is a clinical study titled "Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease". This project aims to validate sex-specific biologic signatures associated with aortic valve disease developed in a large multicenter CMR registry, using unsupervised phenomapping. The aim to use standard and advanced CMR techniques (MRF, DTI, chemical exchange transfer, and radiomics analysis) is t...
What is the current status of trial NCT06780241?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-12-10. Estimated completion is 2030-12-31.
What conditions does trial NCT06780241 study?
This clinical trial studies the following conditions: Aortic Stenosis, Mitral Regurgitation, Aortic Regurgitation.
What interventions are being tested in trial NCT06780241?
The interventions under investigation include: CMR (DIAGNOSTIC_TEST), Quality of Life Questionnaire (OTHER).
Who is sponsoring clinical trial NCT06780241?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06780241 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Loss of Y Chromosome in Aortic Stenosis
RECRUITING
-
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
RECRUITING · Phase 2
-
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
RECRUITING
-
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
RECRUITING · NA
-
Comparative Imaging Assessment of Valvular Heart Disease
RECRUITING
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.